The Bob Harrington Show

Bob Harrington and Mike Gibson continue their review of 2020, discussing the 'riddle wrapped in an enigma' that was the COVID-19 pandemic.

The annual tradition continues as did cardiology research despite a pandemic. Trials on fish oils, statins, SGLT2 inhibitors, and antiplatelets are among the selections of Drs Harrington and Gibson.

Three editors of cardiology journals -- Drs Harrington, Yancy, and Nallamothu -- discuss the challenges of maintaining quality during the COVID-19 surge in submissions.

Hematologist Mary Cushman discusses arterial and venous thrombosis issues with SARS-CoV-2 and the role of anticoagulation.

Bob Harrington asks Michelle Albert why mortality rates are so high in minority communities, and whether COVID-19 will lead to meaningful changes in health and social inequities.

'They fancy themselves free. And no one will ever be free so long as there are pestilences,' wrote Camus in 'The Plague', which Abraham Verghese sees as relevant to our collective experience of COVID-19.

Cardiologist Lisa Rosenbaum seeks meaning in her work as a physician and correspondent for the New England Journal of Medicine, a quest first started by her grandfather who was also a physician-writer.

Bob Harrington and Mike Gibson continue their review of 2019 with the 'hottest trial of the year' and what to expect in healthcare in 2020.

'It's like we're in the '90s again.' Drs Gibson and Harrington review top cardiology trials on revascularization, lipid management, and antithrombotics in part 1 of their annual wrap-up.

A family history of sudden death was the impetus for author Sandeep Juahar's fascination with the heart, which led to a career in cardiology and his latest book Heart: A History.